Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

iBio, Inc. Director's Dealing 2012

Mar 28, 2012

35045_dirs_2012-03-28_7d36376f-4dc0-4c0f-bc37-693fe83f9944.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2012-03-14

Reporting Person: MCKEY JOHN D JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-14 Common Stock S 1150 $1.08 Disposed 993545 Indirect
2012-03-14 Common Stock S 4000 $0.99 Disposed 989545 Indirect
2012-03-15 Common Stock S 3408 $.99 Disposed 986137 Indirect
2012-03-16 Common Stock S 100 $1.04 Disposed 986037 Indirect
2012-03-16 Common Stock S 17753 $.99 Disposed 968284 Indirect

Footnotes

F1: Transaction by spouse of the Reporting Person.

F2: This amendment is being filed to include in the total amount beneficially held an additional 100,000 shares of Common Stock purchased in January 2012, which purchase was reported on a Form 4 at such time. The reported amount includes 206,667 shares of Common Stock underlying vested stock options held by the Reporting Person.

F3: The Reporting Person may be deemed to be the indirect beneficial owner of shares held by his spouse under Rule 16a-1(a)(2) promulgated under the Exchange Act. However, pursuant to Rule 16a-1(a)(4) promulgated under the Exchange Act, the Reporting Person disclaims beneficial ownership of such shares.